KIORA PHARMACEUTICALS INC
Developing advanced small molecule therapies for vision-threatening retinal diseases.
KPRX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US49721T3095
- LEI:
- Country:
- United States of America
- Address:
- 169 SAXONY RD., 92024 ENCINITAS
- Website:
- https://kiorapharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Kiora Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing advanced therapies for retinal diseases. The company utilizes innovative small molecules to target critical biological pathways that underlie vision-threatening conditions. Kiora's development pipeline concentrates on ophthalmic diseases with limited or no effective treatments, aiming to slow, stop, or restore vision loss for patients with these unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all KIORA PHARMACEUTICALS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for KIORA PHARMACEUTICALS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KIORA PHARMACEUTICALS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
